Gene: MAPK4
Official Full Name: mitogen-activated protein kinase 4provided by HGNC
Gene Summary: Mitogen-activated protein kinase 4 is a member of the mitogen-activated protein kinase family. Tyrosine kinase growth factor receptors activate mitogen-activated protein kinases which then translocate into the nucleus and phosphorylate nuclear targets. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35916 | MAPK4 Knockout cell line (HeLa) | Human | MAPK4 | 1:3~1:6 | Negative | Online Inquiry |
KO35917 | MAPK4 Knockout cell line (HEK293) | Human | MAPK4 | 1:3~1:6 | Negative | Online Inquiry |
MAPK4 Gene Knockout Cell Lines are specialized mammalian cell lines engineered to exhibit a complete knockout of the MAPK4 gene, which encodes for mitogen-activated protein kinase 4, a crucial protein kinase involved in various signaling pathways known to regulate cellular processes such as proliferation, differentiation, and apoptosis. By disrupting the expression of MAPK4, these cell lines provide researchers the ability to investigate the downstream effects on cellular behaviors and the broader implications of MAPK signaling in physiological and pathological contexts.
Functionally, MAPK4 serves as a key mediator in response to extracellular signals, activating multiple pathways that ultimately influence gene expression and cell fate. The knockout of this gene permits a clearer understanding of its role in specific signaling cascades, facilitating investigations into disease mechanisms such as cancer progression, inflammatory responses, and developmental biology. MAPK4 knockout models also serve as powerful tools for drug discovery and therapeutic targeting since they allow for the evaluation of potential compounds that may selectively affect MAPK4-related pathways.
One of the critical advantages of our MAPK4 Gene Knockout Cell Lines is the precision with which they have been generated. Utilizing advanced CRISPR-Cas9 technology ensures an exact and stable knockout, mitigating the variability often associated with traditional knockout methods. Additionally, these cell lines are readily accessible and compatible with a variety of cell-based assays, providing versatile applications in both in vitro and in vivo studies.
For researchers and clinicians focused on elucidating the complexity of MAPK signaling and its implications in human health, these knockout cell lines represent an invaluable asset. They not only enhance the rigor of experimental designs but also accelerate the pace of discoveries in various research fields. Our company prides itself on delivering high-quality biological products backed by stringent quality controls and extensive expertise in gene editing technologies, ensuring that our customers have the best tools available to advance their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.